Health-related quality of life is related to cytokine levels at 12 months in patients with chronic heart failure

Brain, Behavior, and Immunity

Volumn 24, Issue 4, 2010, Pages 615-622

  Mommersteeg, Paula M C ^a   Kupper, Nina ^a   Schoormans, Dounya ^a,b   Emons, Wilco ^a,c   Pedersen, Susanne S ^a  

^a Center of Research on Psychology in Somatic Diseases   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c TILBURG UNIVERSITY   (Netherlands)

Author keywords

Anti inflammatory; Chronic heart failure; Cytokines; Health related quality of life; Minnesota Living with Heart Failure Questionnaire; Pro inflammatory; Short Form Health Survey 36

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; CYTOKINE; IL1RN PROTEIN, HUMAN;

AGE DETERMINATION; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL DISEASE; HEART FAILURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENTAL COMPONENT SUMMARY; MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE; MORBIDITY; MORTALITY; PHYSICAL COMPONENT SUMMARY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; SEX DETERMINATION; SHORT FORM 36; SMOKING; TREATMENT DURATION; BLOOD; CHRONIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH SURVEY; IMMUNOLOGY; MIDDLE AGED; OUTPATIENT; PROSPECTIVE STUDY; PSYCHOLOGY; RISK FACTOR; STATISTICAL MODEL;

AGED; CHRONIC DISEASE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH SURVEYS; HEART FAILURE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-10; INTERLEUKIN-6; LINEAR MODELS; MALE; MIDDLE AGED; OUTPATIENTS; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77951880763     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.01.004     Document Type: Article

References (35)

1. Blum A. Heart failure - new insights. Isr. Med. Assoc. J. 2009, 11:105-111.
2. Braunwald E. Biomarkers in heart failure. N. Eng. J. Med. 2008, 358:2148-2159.
3. Carels R.A. The association between disease severity, functional status, depression and daily quality of life in congestive heart failure patients. Qual. Life Res. 2004, 13:63-72.
4. Conraads V.M., Denollet J., De Clerck L.S., Stevens W.J., Bridts C., Vrints C.J. Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure. Int. J. Cardiol. 2006, 113:34-38.
5. Denollet J., Conraads V.M., Brutsaert D.L., De Clerck L.S., Stevens W.J., Vrints C.J. Cytokines and immune activation in systolic heart failure: the role of Type D personality. Brain Behav. Immun. 2003, 17:304-309.
6. El-Menyar A.A. Cytokines and myocardial dysfunction: state of the art. J. Card. Fail. 2008, 14:61-74.
7. Ferketich A.K., Ferguson J.P., Binkley P.F. Depressive symptoms and inflammation among heart failure patients. Am. Heart J. 2005, 150:132-136.
8. Ferrari R., Bachetti T., Confortini R., Opasich C., Febo O., Corti A., Cassani G., Visioli O. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995, 92:1479-1486.
9. Field A. Discovering Statistics Using SPSS 2009, SAGE Publications, London.
10. Genser B., Cooper P.J., Yazdanbakhsh M., Barreto M.L., Rodrigues L.C. A guide to modern statistical analysis of immunological data. BMC Immunol. 2007, 8:27.
11. Goldberg R.J., Konstam M.A. Assessing the population burden from heart failure: need for sentinel population-based surveillance systems. Arch. Intern. Med. 1999, 159:15-17.
12. He J., Ogden L.G., Bazzano L.A., Vupputuri S., Loria C., Whelton P.K. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch. Intern. Med. 2001, 161:996-1002.
13. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., Jessup M., Konstam M.A., Mancini D.M., Michl K., Oates J.A., Rahko P.S., Silver M.A., Stevenson L.W., Yancy C.W., Antman E.M., Smith S.C., Adams C.D., Anderson J.L., Faxon D.P., Fuster V., Halperin J.L., Hiratzka L.F., Jacobs A.K., Nishimura R., Ornato J.P., Page R.L., Riegel B. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005, 112:e154-235.
14. Janszky I., Lekander M., Blom M., Georgiades A., Ahnve S. Self-rated health and vital exhaustion, but not depression, is related to inflammation in women with coronary heart disease. Brain Behav. Immun. 2005, 19:555-563.
15. Juenger J., Schellberg D., Kraemer S., Haunstetter A., Zugck C., Herzog W., Haass M. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 2002, 87:235-241.
16. Krumholz H.M., Peterson E.D., Ayanian J.Z., Chin M.H., DeBusk R.F., Goldman L., Kiefe C.I., Powe N.R., Rumsfeld J.S., Spertus J.A., Weintraub W.S. Report of the National Heart, Lung, and Blood Institute working group on outcomes research in cardiovascular disease. Circulation 2005, 111:3158-3166.
17. Lekander M., Elofsson S., Neve I.M., Hansson L.O., Unden A.L. Self-rated health is related to levels of circulating cytokines. Psychosom. Med. 2004, 66:559-563.
18. Masoudi F.A., Rumsfeld J.S., Havranek E.P., House J.A., Peterson E.D., Krumholz H.M., Spertus J.A. Age, functional capacity, and health-related quality of life in patients with heart failure. J. Card. Fail. 2004, 10:368-373.
19. Mommersteeg P.M.C., Denollet J., Spertus J.A., Pedersen S.S. Health status as a risk factor in cardiovascular disease: A systematic review of current evidence. Am. Heart J. 2009, 157:208-218.
20. Moorman A.J., Mozaffarian D., Wilkinson C.W., Lawler R.L., McDonald G.B., Crane B.A., Spertus J.A., Russo J.E., Stempien-Otero A.S., Sullivan M.D., Levy W.C. In patients with heart failure elevated soluble TNF-receptor 1 is associated with higher risk of depression. J. Card. Fail. 2007, 13:738-743.
21. O'Connor M.F., Bower J.E., Cho H.J., Creswell J.D., Dimitrov S., Hamby M.E., Hoyt M.A., Martin J.L., Robles T.F., Sloan E.K., Thomas K.S., Irwin M.R. To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers. Brain Behav. Immun. 2009, 23:887-897.
22. Orus J., Roig E., Perez-Villa F., Pare C., Azqueta M., Filella X., Heras M., Sanz G. Prognostic value of serum cytokines in patients with congestive heart failure. J. Heart Lung Transplant. 2000, 19:419-425.
23. Parissis J.T., Adamopoulos S., Rigas A., Kostakis G., Karatzas D., Venetsanou K., Kremastinos D.T. Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am. J. Cardiol. 2004, 94:1326-1328.
24. Parissis J.T., Nikolaou M., Farmakis D., Paraskevaidis I.A., Bistola V., Venetsanou K., Katsaras D., Filippatos G., Kremastinos D.T. Self-assessment of health status is associated with inflammatory activation and predicts long-term outcomes in chronic heart failure. Eur. J. Heart Fail. 2009, 11:163-169.
25. Rector T.S., Cohn J.N. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am. Heart J. 1992, 124:1017-1025.
26. Riedinger M.S., Dracup K.A., Brecht M.L. Predictors of quality of life in women with heart failure. SOLVD investigators. Studies of left ventricular dysfunction. J. Heart Lung Transplant. 2000, 19:598-608.
27. Safranow K., Dziedziejko V., Rzeuski R., Czyzycka E., Wojtarowicz A., Binczak-Kuleta A., Jakubowska K., Olszewska M., Ciechanowicz A., Kornacewicz-Jach Z., Machalinski B., Pawlik A., Chlubek D. Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease. Tissue Antigens 2009, 74:386-392.
28. Schiffer A.A., Denollet J., Widdershoven J.W., Hendriks E.H., Smith O.R. Failure to consult for symptoms of heart failure in patients with a type-D personality. Heart 2007, 93:814-818.
29. Spertus J.A. Evolving applications for patient-centered health status measures. Circulation 2008, 118:2103-2110.
30. Stanek E.J., Oates M.B., McGhan W.F., Denofrio D., Loh E. Preferences for treatment outcomes in patients with heart failure: symptoms versus survival. J. Card. Fail. 2000, 6:225-232.
31. Tabachnick B.G., Fidell L.S. Using Multivariate Statistics 2007, Pearson Education Inc., Boston.
32. Uh H.W., Hartgers F.C., Yazdanbakhsh M., Houwing-Duistermaat J.J. Evaluation of regression methods when immunological measurements are constrained by detection limits. BMC Immunol. 2008, 9:59.
33. van Buuren S., Oudshoorn C.G.M. Flexible Multivariate Imputation by MICE 1999, TNO Preventie en Gezondheid, Leiden, pp. 1-20.
34. van Jaarsveld C.H., Sanderman R., Ranchor A.V., Ormel J., van Veldhuisen D.J., Kempen G.I. Gender-specific changes in quality of life following cardiovascular disease: a prospective study. J. Clin. Epidemiol. 2002, 55:1105-1112.
35. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 1992, 30:473-483.